Compare DERM & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | INGN |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 177.1M |
| IPO Year | 2021 | 2013 |
| Metric | DERM | INGN |
|---|---|---|
| Price | $6.49 | $6.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $12.67 | $11.25 |
| AVG Volume (30 Days) | 144.4K | ★ 199.3K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.72 | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | $61,858,000.00 | ★ $348,668,000.00 |
| Revenue This Year | $39.72 | $8.03 |
| Revenue Next Year | $63.24 | $7.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.20 | 3.86 |
| 52 Week Low | $4.31 | $5.34 |
| 52 Week High | $9.56 | $9.13 |
| Indicator | DERM | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 49.39 |
| Support Level | $5.85 | $6.00 |
| Resistance Level | $6.59 | $6.77 |
| Average True Range (ATR) | 0.33 | 0.26 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 39.26 | 45.68 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.